DPI
ABBV icon

Diversified Portfolios Inc’s AbbVie ABBV Stock Holding History

Diversified Portfolios Inc’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
6,557
+1,664
+34% +$358K 0.12% 87
2026
Q1 		$1.06M Sell
4,893
-801
-14% -$178K 0.09% 95
2025
Q4 		$1.3M Buy
5,694
+525
+10% +$120K 0.11% 85
2025
Q3 		$1.2M Sell
5,169
-61
-1% -$12.4K 0.11% 82
2025
Q2 		$971K Buy
5,230
+69
+1% +$12.8K 0.09% 86
2025
Q1 		$1.08M Sell
5,161
-222
-4% -$43.2K 0.11% 81
2024
Q4 		$957K Sell
5,383
-246
-4% -$45.2K 0.1% 80
2024
Q3 		$1.11M Buy
5,629
+2
+0% +$373 0.12% 76
2024
Q2 		$965K Sell
5,627
-2,694
-32% -$446K 0.13% 78
2024
Q1 		$1.52M Sell
8,321
-366
-4% -$63.1K 0.21% 56
2023
Q4 		$1.35M Sell
8,687
-17
-0.2% -$2.48K 0.21% 54
2023
Q3 		$1.3M Buy
8,704
+17
+0.2% +$2.5K 0.24% 50
2023
Q2 		$1.17M Sell
8,687
-501
-5% -$73.5K 0.23% 54
2023
Q1 		$1.46M Hold
9,188
– – 0.33% 45
2022
Q4 		$1.48M Sell
9,188
-130
-1% -$19.9K 0.34% 39
2022
Q3 		$1.25M Sell
9,318
-1,591
-15% -$228K 0.34% 42
2022
Q2 		$1.67M Sell
10,909
-500
-4% -$76.4K 0.47% 36
2022
Q1 		$1.85M Sell
11,409
-222
-2% -$32.2K 0.44% 38
2021
Q4 		$1.57M Hold
11,631
– – 0.38% 41
2021
Q3 		$1.25M Hold
11,631
– – 0.35% 38
2021
Q2 		$1.31M Buy
11,631
+4,492
+63% +$506K 0.49% 28
2021
Q1 		$773K Buy
7,139
+4,373
+158% +$468K 0.25% 45
2020
Q4 		$296K Hold
2,766
– – 0.11% 75
2020
Q3 		$242K Buy
+2,766
New +$260K 0.1% 64
2015
Q1 		– Sell
-11,118
Closed -$728K – 54
2014
Q4 		$728K Buy
+11,118
New +$701K 0.43% 26

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Diversified Portfolios Inc's ABBV Position: Q2 2026 in Review

Diversified Portfolios Inc increased its AbbVie (ABBV) stake by 34% in Q2 2026, buying an estimated $358K and bringing the position to 6,557 shares worth $1.65M. The position accounts for 0.12% of the portfolio, ranked #87.

Diversified Portfolios Inc first reported a position in ABBV in Q4 2014 and has held it in 25 quarters since. The position peaked at $1.85M in Q1 2022. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Diversified Portfolios Inc held 6,557 shares of AbbVie worth $1.65M as of Q2 2026.
  • Diversified Portfolios Inc bought 1,664 AbbVie shares in Q2 2026, an estimated $358K.
  • AbbVie made up 0.12% of Diversified Portfolios Inc's portfolio in Q2 2026, its #87 holding.
  • Diversified Portfolios Inc first reported a position in AbbVie in Q4 2014 and has held it in 25 quarters since.
  • Diversified Portfolios Inc's AbbVie position peaked at $1.85M in Q1 2022.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Diversified Portfolios Inc's 13F filing for Q2 2026, filed 4 Aug 2026.